64695-92-7

Usage

Uses

Used in Pharmaceutical Industry:
2-Carboxy-5-fluoro-4-nitrotoluene, 5-Carboxy-2-fluoro-4-methylnitrobenzene is used as a chemical intermediate for the synthesis of pharmaceuticals. Their unique functional groups contribute to the development of new drugs with specific therapeutic properties.
Used in Dye Industry:
2-Carboxy-5-fluoro-4-nitrotoluene, 5-Carboxy-2-fluoro-4-methylnitrobenzene is used as a chemical intermediate for the production of dyes. Their aromatic structures and functional groups enable the creation of dyes with desired color properties and stability.
Used in Agrochemical Industry:
2-Carboxy-5-fluoro-4-nitrotoluene, 5-Carboxy-2-fluoro-4-methylnitrobenzene is used as a chemical intermediate in the synthesis of agrochemicals. Their versatile chemical structures allow for the development of effective pesticides and other agricultural chemicals.
Used in Polymer Production:
2-Carboxy-5-fluoro-4-nitrotoluene, 5-Carboxy-2-fluoro-4-methylnitrobenzene is used as a monomer or a building block in the production of polymers. Their functional groups can be incorporated into polymer chains, resulting in materials with specific properties and applications.
Used as Reagents in Organic Synthesis:
2-Carboxy-5-fluoro-4-nitrotoluene, 5-Carboxy-2-fluoro-4-methylnitrobenzene is used as reagents in various organic synthesis processes. Their reactive functional groups facilitate a wide range of chemical reactions, enabling the synthesis of diverse organic compounds for various applications.

Upstream product

• 321-21-1 4-fluoro-2-methylbenzoic acid 
• 352-70-5 m-Fluorotoluene 
• 75-36-5 acetyl chloride 

Downstream Products

• 1191428-67-7 C₈H₈FNO₃ 
• 1163287-01-1 methyl 4-fluoro- 2-methyl-5-nitrobenzoate 
• 1447363-95-2 2-methyl-5-nitro-4-(4-o-tolylpiperazin-1-yl)benzoic acid 
• 1447364-01-3 C₂₃H₂₈N₄O₄ 
• 1447364-00-2 C₂₀H₂₃N₃O₄ 
• 1447363-98-5 7-nitro-2-[3-(2-oxooxazolidin-3-yl)propyl]-6-(4-o-tolylpiperazin-1-yl)-2H-isoquinolin-1-one 
• 1447363-97-4 7-nitro-6-(4-o-tolylpiperazin-1-yl)-2H-isoquinolin-1-one 
• 1447363-96-3 2-methyl-5-nitro-4-(4-o-tolylpiperazin-1-yl)benzamide 
• 1338346-22-7 5-amino-2-methyl-4-{[2-(methyloxy)ethyl]amino}benzoic acid 
• 1338346-21-6 2-methyl-4-{[2-(methyloxy)ethyl]amino}-5-nitrobenzoic acid 
• 658085-42-8 5-amino-4-fluoro-2-methylbenzoic acid 

Relevant academic research and scientific papers

HEPATITIS B CORE PROTEIN MODULATORS

The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound of formula:

HEPATITIS B CORE PROTEIN MODULATORS

The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS

ABSTRACT The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE

Novel benzamide derivatives of formula (I) wherein W1, W2, R1 to R10 and X have the meaning according to the claims, are positive allosteric modulators of the FSH receptor, and can be employed, inter alia, for the treatment of fertility disorders.

IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS

Disclosed are compounds having the formula: wherein R1A, R1B, R2 and R3 are as defined herein, and methods of making and using the same.

Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists

Recently sulfamoyl benzamides were identified as a novel series of cannabinoid receptor ligands. Replacing the sulfonamide functionality and reversing the original carboxamide bond led to the discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists. Selective CB2 agonist 31 (Ki = 2.7; CB1/CB2 = 190) displayed robust activity in a rodent model of postoperative pain.